Chemed Deferred Long Term Liab from 2010 to 2026
| CXM Stock | EUR 358.00 12.00 3.47% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 1.5 M | Current Value 1.5 M | Quarterly Volatility 38.8 M |
Check Chemed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemed's main balance sheet or income statement drivers, such as Interest Expense of 2.3 M, Selling General Administrative of 352.2 M or Total Revenue of 2.2 B, as well as many indicators such as . Chemed financial statements analysis is a perfect complement when working with Chemed Valuation or Volatility modules.
Chemed | Deferred Long Term Liab |
The Deferred Long Term Liab trend for Chemed offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Chemed is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Chemed's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Chemed over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Chemed's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemed's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Chemed Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 36,509,751 | |
| Geometric Mean | 7,425,439 | |
| Coefficient Of Variation | 106.29 | |
| Mean Deviation | 37,481,646 | |
| Median | 1,703,000 | |
| Standard Deviation | 38,805,287 | |
| Sample Variance | 1505.9T | |
| Range | 78.2M | |
| R-Value | (0.87) | |
| Mean Square Error | 383.8T | |
| R-Squared | 0.76 | |
| Slope | (6,703,984) | |
| Total Sum of Squares | 24093.6T |
Chemed Deferred Long Term Liab History
About Chemed Financial Statements
Chemed stakeholders use historical fundamental indicators, such as Chemed's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Chemed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemed's assets and liabilities are reflected in the revenues and expenses on Chemed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemed. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 1.5 M | 1.5 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Chemed Stock
Chemed financial ratios help investors to determine whether Chemed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chemed with respect to the benefits of owning Chemed security.